Essex Financial Services’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Essex Financial Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$545K	Sell	16,075 -72	-0.4%	-$2.4K	0.03%	459
2026 Q1	$486K	Sell	16,147 -385	-2%	-$12.4K	0.03%	466
2025 Q4	$516K	Sell	16,532 -41	-0.2%	-$1.01K	0.03%	432
2025 Q3	$335K	Sell	16,573 -1	-0%	-$18	0.02%	545
2025 Q2	$278K	Sell	16,574 -292	-2%	-$4.71K	0.02%	574
2025 Q1	$259K	Sell	16,866 -102	-0.6%	-$1.82K	0.02%	533
2024 Q4	$374K	Sell	16,968 -402	-2%	-$7.31K	0.03%	438
2024 Q3	$319K	Buy	+17,370	New	+$304K	0.02%	477

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Essex Financial Services's TEVA Position: Q2 2026 in Review

Essex Financial Services reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 0.45% in Q2 2026, selling an estimated $2.4K and leaving 16,075 shares worth $545K. The position accounts for 0.03% of the portfolio, ranked #459.

Essex Financial Services first reported a position in TEVA in Q3 2024 and has held it in 8 quarters since. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Essex Financial Services held 16,075 shares of Teva Pharmaceutical Industries Limited worth $545K as of Q2 2026.
Essex Financial Services sold 72 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $2.4K.
Teva Pharmaceutical Industries Limited made up 0.03% of Essex Financial Services's portfolio in Q2 2026, its #459 holding.
Essex Financial Services first reported a position in Teva Pharmaceutical Industries Limited in Q3 2024 and has held it in 8 quarters since.
677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Essex Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.